Study on the relationship between the polymorphism of p53 gene intron 7 and non-small cell lung cancer (NSCLC) and p53 mutation in NSCLC tissues

Chinese Journal of Medical Genetics

Volumn 24, Issue 3, 2007, Pages 319-321

  Gu, Qi Hua ^a   Chen, Qiong ^a   Hu, Cheng Ping ^a   Li, Ye Qing ^b   Yang, Hong Zhong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Fifth People's Hospital of Huaihua   (China)

Author keywords

Gene mutation; Gene polymorphism; Intron; Lung neoplasm; p53 gene

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTRON; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENES, P53; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTRONS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC;

EID: 34250815628     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ge H, Lam WK, Lee J, et al. Detection and evaluation of p53 intron 2 polymorphism in lung cancer in Hong Kong. Int J Can, 1996,69:120-124.
2. Biros E, Kalina I, Kohut A, et al. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer, 2001,31:157-162.
3. Gu QH, Shu C, Ye AH, et al. An analysis of two polymorphic points of the 7th intron of human p53 gene. Chin J Med Genet, 2000, 17:161-163.
4. Berggren P, Hemminki K, Steineck G. p53 intron 7 polymorphisms in urinary bladder cancer patients and controls. Mutagenesis, 2000,15:57-60.
5. Berggren P, Kumar R, Steineck G, et al. Ethnic variation in genotype frequencies of a p53 intron 7 polymorphism. Mutagenesis, 2001, 16:475-478.
6. Nott A, Meislin SH, Moore MJ. A quantitative analysis of intron effects on mammalian gene expression. RNA, 2003,9:607-617.
7. Wang XB, Liu GY. New progress in functional study of gene introns. Chin J Med Genet, 2000, 17:211-212.
8. Hinds P, Finlay C, Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol, 1989,63:739-746.
9. Takahashi T, D'Amico D, Chiba I, et al. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest, 1990,86:363-369.
10. Voglino G, Castello S, Silengo L, et al. An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer. Eur J Cancer, 1997,33:1479-1483.
11. Hartmann A, Blaszyk H, Mcgorern RM, et al. p53 gene mutation inside and outside of exons 5-8: the patterns differ in breast and other cancer. Oncogene, 1995,10:681-688.